secwatch.observer — SEC 8-K summary
======================================

Issuer:     Zivo Bioscience, Inc. (ZIVO)
CIK:        0001101026
Form:       8-K
Filed at:   2023-06-16T23:59:59+00:00
Accession:  0001654954-23-008091
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Zivo Bioscience stockholders elect Maggiore, ratify BDO, approve exec compensation
--------------------------------------------------------------------------------

- Christopher D. Maggiore elected to board with 3,050,053 votes for, 393,297 withheld; 2,704,419 broker non-votes.
- BDO USA, LLP ratified as auditor for FY2023: 5,982,232 for, 164,958 against, 579 abstain.
- Advisory vote on executive compensation approved: 3,252,348 for, 186,946 against, 4,056 abstain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1101026/000165495423008091/0001654954-23-008091-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1101026/000165495423008091/zivo_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-23-008091

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer